Full Text
RWD42 ECONOMIC EVALUATION OF NEOADJUVANT-ADJUVANT VERSUS ADJUVANT-ONLY PEMBROLIZUMAB IN RESECTABLE MELANOMA

Abstract

Authors

Qiran Wei Joyce You YINGCHENG WANG Mingjun Rui

Back to Volume 49, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×